Preparation of ZnO nanoparticles in a reverse micellar system and their photoluminescence properties.

ZnO nanoparticles with spherical morphology and narrow size distribution were obtained by calcination of Zn(OH)2 nanoparticles, which were prepared in a polyethylene glycol mono-4-nonylphenyl ether (NP-5)/cyclohexane reverse micellar system and incorporated into polyurea (PUA) via an in situ polymerization of hexamethylene diisocyanate (HDI). The resulting ZnO nanoparticles demonstrated a near-UV emission and a green emission, the intensity ratio of which depended on calcination conditions. For the nanoparticles studied, the calcination atmosphere influenced remarkably the photoluminescence properties such as intensity ratio of the near-UV emission to green emission, rather than the size, morphology, and crystallinity of the ZnO nanoparticles. The green emission decreased by calcination in O2 flow but increased by calcination in N2 flow, as compared with the case calcined in air flow. This finding suggests that the green emission is enhanced with the increase of the number of oxygen vacancies of the ZnO nanoparticles and thus the photoluminescence properties of the nanoparticles were successfully controlled by the calcination condition, without changing the size and morphology.

Preparation of Y2O3:Eu3+ nanoparticles in reverse micellar systems and their photoluminescence properties.

Y2O3:Eu3+ phosphor nanoparticles (4-8 nm in size) with spherical morphology and narrow size distribution were obtained by calcination of composite Y-Eu hydroxide nanoparticles, which were prepared in sodium bis(2-ethylhexyl)sulfosuccinate (AOT)/isooctane or polyethylene glycol mono-4-nonylphenyl ether (NP-5)/cyclohexane reverse micellar systems. This was achieved by the incorporation of the Y-Eu hydroxide nanoparticles into polyurea (PUA) via in situ polymerization of hexamethylene diisocyanate (HDI) in the reverse micellar solution and subsequent calcination of the resulting PUA materials. The emission intensity of the Y2O3:Eu3+ nanoparticles, prepared in the AOT/isooctane system, was significantly lower than that of the micrometer-size particles prepared in a homogeneous aqueous solution, since the calcined nanoparticles contained Na2SO4 impurity derived from the remaining AOT surfactant. The nanoparticles prepared in the NP-5/cyclohexane system, in contrast, showed higher emission intensity compared to the nanoparticles prepared in the AOT/isooctane system and longer luminescence lifetime compared to the micrometer-size particles prepared in the homogeneous aqueous solution. The photoluminescence intensity of Y2O3:Eu3+, prepared via the proposed process was found to decrease with decreasing the particle size.

Molecular evolution of IgG subclass among nonhuman primates: implication of differences in antigenic determinants among Apes.

The cross-reactivity of five different rabbit polyclonal antibodies to human IgG and IgG subclass (IgG1, IgG2, IgG3, and IgG4) was determined by competitive ELISA with nine nonhuman primate species including five apes, three Old World monkeys, and one New World monkey. As similar to those previously reported, the reactivity of anti-human IgG antibody with plasma from different primate species was closely related with phylogenic distance from human. Every anti-human IgG subclass antibody showed low cross-reactivity with plasma from Old World and New World monkeys. The plasma from all apes except for gibbons (Hylobates spp.) showed 60 to 100% of cross-reactivity with anti-human IgG2 and IgG3 antibodies. On the other hand, chimpanzee (Pan troglodytes and Pan paniscus) and orangutan (Pongo pygmaeus) plasma showed 100% cross-reactivity with anti-human IgG1 antibody, but gorilla (Gorilla gorilla) and gibbon plasma showed no cross-reactivity. The chimpanzee and gorilla plasma cross-reacted with anti-human IgG4 antibody at different reactivity, 100% in chimpanzee and 50% in gorilla, but no cross-reactivity was observed in orangutan and gibbon plasma. These results suggest the possibilities that the divergence of "human-type" IgG subclasses might occur at the time of divergence of Homo sapience from Hylobatidae, and that the molecular evolution of IgG1 as well as IgG4 is different from that of IgG2 and IgG3 in great apes, this is probably caused by different in development of immune function in apes during the course of evolution.